Cargando…
New COVID-19 Variant, VUI-202012/01: Molecular Change, Epitope Alteration, and Implication for Vaccine Efficacy
Autores principales: | Joob, Beuy, Wiwanitkit, Viroj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724792/ https://www.ncbi.nlm.nih.gov/pubmed/35070205 http://dx.doi.org/10.4103/ijpvm.IJPVM_708_20 |
Ejemplares similares
-
Implications of the Emergence of a New Variant of SARS-CoV-2, VUI-202012/01
por: Rahimi, Farid, et al.
Publicado: (2021) -
Expected efficacy of HPV vaccine in prevention of cervix cancer in Thailand
por: Joob, Beuy, et al.
Publicado: (2014) -
Cytokine Receptor Allele Frequency, Immunogenicity, and Efficacy of New COVID-19 Vaccine in Different Setting
por: Joob, Beuy, et al.
Publicado: (2023) -
Dieckol and Its Derivatives as Potential Inhibitors of SARS-CoV-2 Spike Protein (UK Strain: VUI 202012/01): A Computational Study
por: Aatif, Mohammad, et al.
Publicado: (2021) -
Alteration of Consciousness as Initial Presentation in COVID-19: Observation
por: Joob, Beuy, et al.
Publicado: (2020)